LabConnect, a global leader in central laboratory services, has announced a strategic collaboration with OmniScience, the AI company behind Vivo, the industry’s first agent-based AI control tower for clinical trials. This partnership will introduce the first AI-driven solution designed to provide sponsors with intelligent, real-time insights from clinical trial laboratory data.
Clinical trial data is often fragmented, complex, and delayed slowing decision-making and increasing risk. By integrating LabConnect’s expertise in centralized laboratory testing and data management with OmniScience’s Vivo platform, sponsors can now unify disparate lab data sets, automate monitoring, and detect risk signals earlier. This enables faster decision-making, improved study efficiency, and higher-quality results.
Vivo: A Next-Generation Clinical Trial Intelligence Platform
Vivo is an AI-native platform purpose-built to transform how research teams interact with clinical trial data across the development lifecycle. Designed as a control tower, Vivo consolidates siloed data sources and delivers real-time intelligence to clinical, operational, safety, and data science teams allowing them to respond with greater clarity and confidence.
Its specialized extension, Vivo-Lab, applies this capability directly to laboratory data, streamlining workflows and uncovering trends, anomalies, and deviations as they occur at the site level. This proactive approach helps sponsors move from reactive monitoring to real-time intelligence addressing one of the most variable and complex data streams in clinical research.
Also Read: Lila Sciences Secures $235M to Expand AI Research Program
Driving Real-Time Action from Lab Data
“Our goal at OmniScience is to help study teams detect and act faster,” explains Angela Holmes, CEO and co-founder of OmniScience. “The partnership with LabConnect extends this mission by transforming real-time lab data into actionable information sponsors can trust.”
Wes Wheeler, CEO of LabConnect, adds, “At LabConnect, we empower clinical trial sponsors to unlock the full potential of their laboratory data. By integrating OmniScience’s transformative AI, we transform lab results from static reports into dynamic, actionable information. Together, we provide clinical operations teams with the speed, flexibility, and precision they need to make smarter decisions, improve trial efficiency, and bring therapies to patients faster.”
This collaboration reflects the shared commitment of LabConnect and OmniScience to redefine clinical development through innovation. By merging LabConnect’s technology-enabled laboratory workflows with OmniScience’s AI-powered trial intelligence, the partnership establishes a new industry benchmark for accelerating clinical research and delivering therapies more efficiently.